课题基金 / 基金详情

mAnaging siCkle CELl disease through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE)

mAnaging siCkle CELl disease through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE)
在尼日利亚通过增加羟基脲的使用来控制镰状细胞病(加速)
批准号:
10638598
负责人:
Obiageli Eunice Nnodu
金额:
$70.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-15 至 2028-07-31

项目摘要

项目成果

Obiageli Eunice Nnodu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Large knowledge gaps remain regarding strategies to promote the adoption of hydroxyurea (HU), particularly in sub-Saharan African countries including Nigeria, where more than 75% of annual sickle cell anemia births occur. The vast majority of people with SCD in Africa do not receive evidenced-based health care (e.g., newborn screening, health education, prophylaxis for infection, optimal nutrition and hydration, blood transfusion, transcranial Doppler screening, and HU therapy), despite its effectiveness in reducing SCD-related adverse outcomes and mortality. The use of HU in SSA is <1% among SCD patients. Our preliminary findings indicate that provider-level barriers are significant and must be addressed to improve HU adoption. To address HU adoption we will use the NIH-funded study (e.g., Realizing Effectiveness Across Continents with Hydroxyurea (REACH) Clinical Trial (NCT01966731)) that developed an evidence-informed, clinical, practical, and easy-to- follow algorithm to 1) Screen patients for sickle cell disease (SCD), 2) Initiate HU treatment, and 3) Maintain HU dosage over time (SIM) for the improved management of SCD as our intervention. The Nigerian government released guidelines supporting the SIM intervention for HU adoption for improved SCD management, and HU is on the list of essential medicines for Nigeria. Our implementation strategy for improving SCD management in Nigeria uses a practical and replicable evidence-based task-sharing strategy, TAsk-Strengthening Strategy for Hemoglobinopathies (TASSH), adopted from our TAsk-Strengthening Strategy for Hypertension control (TASSH) trials in Ghana and Nigeria containing the essential components of i) Training healthcare workers/providers to be more patient-centered in clinical consultations, ii) Clinical reminders, and iii) Practice facilitation (TCP) known as (TASSH TCP) for SCD management. Using a sequential exploratory mixed-methods study design, we will conduct this study using the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework in four sequential phases to assess the effectiveness of SIM adoption by providers in the context of the TASSH TCP implementation strategy in Nigeria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sickle Pan African Research Consortium Nigeria (SPARC-NEt)
  • 批准号:
    10634631
  • 项目类别:
  • 资助金额:
    $25.19万
  • 财政年份:
    2021
  • 负责人:
    Obiageli Eunice Nnodu
  • 依托单位:
Sickle Pan African Research Consortium NigEria (SPARC-NEt)
  • 批准号:
    10414923
  • 项目类别:
  • 资助金额:
    $25.26万
  • 财政年份:
    2021
  • 负责人:
    Obiageli Eunice Nnodu
  • 依托单位:
Sickle Pan African Research Consortium NigEria (SPARC-NEt)
  • 批准号:
    10186372
  • 项目类别:
  • 资助金额:
    $22.89万
  • 财政年份:
    2021
  • 负责人:
    Obiageli Eunice Nnodu
  • 依托单位:
海外基金